Porush JGHypertension and chronic renal failure: the use of ACE inhibitors . Am J Kidney Dis1998;31:177-84.
2.
Laffel LM, McGill JB, Gans DJThe beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group. Am J Med1995;99:497-504.
3.
Parving HH, Rossing P., Hommel E. et al. Angiotensin-converting enzyme inhibition in diabetic nephropathy: ten years' experience. Am J Kidney Dis1995 ;26:99-107.
4.
The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia).Randomized placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet1997;349:1857-63.
5.
Ruggenenti P. , Perna A., Gherardi G. et al. Renoprotective properties of ACE inhibition in non-diabetic nephropathies with non-nephrotic proteinuria. Lancet1999;354:359-64.
6.
Mori M., Akatsuka N., Fukazawa M. et al. Endothelium-dependent relaxation by angiotensin converting enzyme inhibitors in canine femoral arteries. Am J Physiol1994;266:H583-H589.
7.
Hollenberg NKACE inhibitors, AT1 receptor blockers, and the kidney. Nephrol Dial Transplant1997;12:381-3.
8.
Hollenberg NKCorcoran Lecture: Implications of species difference for clinical investigation: studies on the renin-angiotensin system . Hypertension2000;35:150-4.
9.
Zimmerman BG , Raich PC,Vavrek RJ et al. Bradykinin contribution to renal blood flow effect of angiotensin converting enzyme inhibitor in the conscious sodium-restricted dog. Circ Res1990;66:234(c)-240.
10.
Endlich K., Steinhausen M.Role of kinins and angiotensin II in the vasodilating action of angiotensin converting enzyme inhibition in rat renal vessels. J Hypertension1997;15:633-41.
11.
Heller J., Kramer HJ, Horacek V.Comparative effects of the angiotensin II receptor blocker EXP 3174 and of the angiotensin converting enzyme inhibitor captopril on renal glomerular hemodynamics in the dog. Kidney Blood Press Res1997;20:391-7.
12.
Matsuda H., Hayashi K., Arakawa K. et al. Zonalheterogeneity in action of angiotensin converting enzyme inhibitor on renal microcirculation: role of intrarenal bradykinin. J Am Soc Nephrol1999;10:2272-82.
13.
Clappison BH , Anderson WP, Johnston CIRenal hemodynamics and renal kinins after angiotensin converting enzyme inhibition . Kidney International1981;20:615-20.
14.
Clappison BH , Anderson WP, Johnston CIRole of the kallikrein-kinin system in the renal effects of angiotensin converting enzyme inhibition in anesthetized dogs. Clin Exp Pharmacol Physiol1981;8:509-13.
15.
Naitoh M., Suzuki H., Arakawa K. et al. Role of kinin and renal AngII blockade in acute effects of ACE inhibitors in low-renin hypertension. Am J Physiol1997;272:H679-H687.
16.
Kon V., Fogo A., Ichikawa I., Hellings SE et al. Bradykinin causes selective efferent arteriolar dilation during angiotensin I converting enzyme inhibition. Kidney Int1993;44:545-50.
17.
AbeY.,Miura K. , Imanishi M. et al. Effects of an orally active converting enzyme inhibitor (YS-980) on renal function in dogs. J Pharmacol Exp Ther1980;214:166-70.
18.
Miura K.,YukimuraT,Imanishi M. et al. Effect of SA-446, an angiotensin-converting enzyme inhibitor, on renal function in anesthetized dogs; special reference to arachidonic acid metabolites. J Cardiovasc Pharmacol1985;7:102-7.
19.
Wong PC, Zimmerman BG, Kraft E. et al. Pharmacological evaluation in conscious dogs of factors involved in the renal vasodilator effect of captopril. J Pharmacol Exp Ther1981; 219:646-50.
20.
Wong PC, Zimmerman BGMechanism of captopril(c)induced renal vasodilation in anesthetized dogs after nonhypotensive hemorrhage. N Pharmacol Exp Ther1980;215:104-9.
21.
Oliver JA, Sciacca RR, Cannon PJRenal vasodilation by converting enzyme inhibition: role of renal prostaglandins . Hypertension1983;5:166-71.
22.
TobiaAJ,Giardino ECRenal vasodilator responses to captopril in dogs pre-treated with indomethacin (41157). Proc Soc Exp Biol Med1981;167:242-7.
23.
Fenoy FJ, Scicli G., Carretero O., Roman RJEffect of an angiotensin II and a kinin receptor antagonist on the renal hemodynamic response to captopril. Hypertension1991;17:1038-44.
24.
Johnston PA , Bernard DB, Perrin NS et al. Control of rat renal vascular resistance during alterations in sodium balance. Circ Res1981;48:728-33.
25.
MimranA,Casellas D., Dupont M.Indirect evidence against a role of the kinin system in the renal hemodynamic effect of captopril in the rat. Kidney Int1980;18:746-53.
26.
Kimbrough HM , Vaughan ED, Carey RM et al. Effect of intrarenal angiotensin II blockade on renal function in conscious dogs. Circ Res1977;40:174-8.
27.
Burger BM, Hopkins T., Tulloch A. et al. The role of angiotensin in the canine and vascular response to barbiturate anesthesia. Circ Res1976;38:196-202.
28.
Omoro SA, Majid DSA, Ed(c)Dahr SS et al. Kinin influences on renal regional blood flow responses to angiotensin-converting enzyme inhibition in dogs. Am J Physiol1999 ;276:F271-F277.
29.
Heller J., Kramer HJ, Horacek V.The effect of kinin and prostaglandin inhibitors on the renal response to angiotensin-converting enzyme inhibition: a micropuncture study in the dog . Pfugers Arch1994;427:219-24.
30.
Zimmerman BG , Goering JL, Raich PCResistance to blockade by saralasin of effect of ACE inhibitors in conscious sodium(c)restricted dog. Am J Physiol1988;255:F944-F952.
31.
Wong PY,Talamo RC, Williams GH et al. Response of the kallikrein-kinin and renin-angiotensin systems to saline infusion and upright posture. J Clin Invest1975;55:691-8.
32.
Mimran A., Guiod L., Hollenberg NKThe role of angiotensin in the cardiovascular and renal response to salt restriction . Kidney Int1974;5:348-55.
33.
Hollenberg NK, Passan DRSpecificity of renal vasodilation with captopril: saralasin prevents the response in the DOCA-treated, salt loaded rabbit. Life Sci1982;31:329-34.
34.
Chen K., Zimmerman BGComparison of renal hemodynamic effect of ramiprilat to captopril; possible role of kinins. J Pharmacol Exp Ther1994;270:491-7.
35.
Toth-Heyn P. , Mosig D., Guignard JPRole of bradykinin in the neonatal renal effects of angiotensin converting enzyme inhibition . Life Sci1998;64:309-18.
36.
Tomoda F.,Lew RA, Smith Al et al. Role of bradykinin receptors in the renal effects of inhibition of angiotensin converting enzyme and endopeptidases 24.11 and 24.15 in conscious rabbits. Br J Pharmacol1996;119:365-73.
37.
Haij-Ali AF , Zimmerman BGKinin contribution to renal vasodilator effect of captopril in rabbit. Hypertension1991;17:504-9.
38.
Swartz SL, Williams GH, Hollenberg NK et al. Captopril-induced changes in prostaglandin production: relationship tovascular responses in normal man. J Clin Invest1980;65:1257-64.
39.
Crantz FR, Swartz SL, Hollenberg NK et al. Role of prostaglandins in the hypotensive response to captopril in essential hypertension. Clin Res1979;27:592.
40.
Hollenberg NK, Williams GH,Taub KJ et al. Renal vascular response to interruption of the renin-angiotensin system in normal man. Kidney Int1977;12:285-93.
41.
Hollenberg NK, Fisher NDL, Price DAPathways for angiotensin II generation in intact human tissue: evidence from comparative pharmacological interruption of the renin system. Hypertension1998;32:387-92.
42.
Gainer JV, Morrow JD, Loveland A. et al. Effect of bradykinin-receptor blockade on the response to angiotensin-converting enzyme inhibitor in normotensive and hypertensive subjects. N Engl J Med1998;339:2285-92.